Agents and methods for diagnosis and therapy of cancer and cancer risk assessment

Agents and methods for diagnosis and therapy of cancer and cancer risk assessment

The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, 000151 PDZ and LIM Domain Protein 1, P55072 Transitional Endoplasmati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TORTOLA PEREZ, SILVIA, SEIBERT, VOLKER, LAMER, STEPHANIE, FOGERON, MARIE-LAURE, VAN DER LINDEN, MARK, HEIM, STEFFEN, ILYNIA, TATIANA, BUSCHMANN, THOMAS, MEUER, JOERN, ROTHMANN, KIRSTEN
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, 000151 PDZ and LIM Domain Protein 1, P55072 Transitional Endoplasmatic Reticulum ATPase, P20142 Gastricsin (pepsinogen C or II), P07492 Beta-2-Glycoprotein I Precursor (apolipoprotein H), P47756 F-Actin Capping Protein Beta subunit, P27824 Calnexin Precursor, P32119 Peroxiredoxin 2, P11021 78 kDa Glucose regulated protein precursor, Q9Y4L1 150 kD Oxygen-regulated Protein Precursor and/or 075493 CA11(downregulated in gastric cancer).